JNJ

JNJ Net Change in Cash

-$8.67BTTM · USD

Period ending:

JNJ FY Net Change in CashUSD
JNJ FY Net Change in Cash1989-12-31: -$77.00M1990-12-31: $374.00M1991-12-31: -$237.00M1992-12-31: $156.00M1993-12-31: -$373.00M1994-12-31: $264.00M1995-12-31: $565.00M1996-12-31: $810.00M1997-12-31: $742.00M1998-12-31: -$826.00M1999-12-31: $369.00M2000-12-31: $1.05B2001-12-31: -$520.00M2002-12-31: -$864.00M2003-12-31: $2.48B2004-12-31: $3.83B2005-12-31: $6.85B2006-12-31: -$11.97B2007-12-31: $3.69B2008-12-31: $3.00B2009-12-31: $5.04B2010-12-31: $3.55B2011-12-31: $5.19B2012-12-31: -$9.63B2013-12-31: $6.02B2014-12-31: -$6.40B2015-12-31: -$791.00M2016-12-31: $5.24B2017-12-31: -$1.15B2018-12-31: $283.00M2019-12-31: -$802.00M2021-01-03: -$3.32B2022-01-02: $502.00M2023-01-01: -$360.00M2023-12-31: $7.73B2024-12-29: $2.25B2025-12-28: -$4.40B$7.73B-$11.97B
1989-12-312025-12-28

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

JNJ net change in cash history

Net period-over-period change in cash balance. The available annual fiscal periods series contains 37 observations from Dec 31, 1989 to Dec 28, 2025.

Johnson & Johnson Net Change in Cash — Annual fiscal periods (USD)
Period endingNet Change in Cash (USD)
-4,396,000,000
2,246,000,000
7,732,000,000
-360,000,000
502,000,000
-3,320,000,000
-802,000,000
283,000,000
-1,148,000,000
5,240,000,000
-791,000,000
-6,404,000,000
6,016,000,000
-9,631,000,000
5,187,000,000
3,545,000,000
5,042,000,000
2,998,000,000
3,687,000,000
-11,972,000,000
6,852,000,000
3,826,000,000
2,483,000,000
-864,000,000
-520,000,000
1,048,000,000
369,000,000
-826,000,000
742,000,000
810,000,000
565,000,000
264,000,000
-373,000,000
156,000,000
-237,000,000
374,000,000
-77,000,000

Compare net change in cash

All JNJ financial metrics · JNJ stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.